tiprankstipranks
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM
US Market

Mirum Pharmaceuticals (MIRM) Ownership - Who Owns Mirum Pharmaceuticals?

Compare
679 Followers

Mirum Pharmaceuticals (MIRM) Ownership Overview

9.43%24.44%40.60%11.98%13.55%
40.60% Other Institutional Investors
11.98% ETFs
13.55% Public Companies and
Individual Investors
The ownership structure of Mirum Pharmaceuticals (MIRM) stock is a mix of institutional, retail, and individual investors. Approximately 77.02% of the company’s stock is owned by Institutional Investors, 9.43% is owned by Insiders, and 13.55% is owned by Public Companies and Individual Investors.
The ownership structure of Mirum Pharmaceuticals (MIRM) stock is a mix of institutional, retail, and individual investors. Approximately 65.04% of the company’s stock is owned by Institutional Investors, 9.43% is owned by Insiders, and 11.98% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 18, 2025
Patrick Heron
Director, >10% Owner
xxxxxxxxxxxxx
$24213
Mar 12, 2025
Patrick Heron
Director, >10% Owner
xxxxxxxxxxxxx
$99506
Mar 10, 2025
Patrick Heron
Director, >10% Owner
xxxxxxxxxxxxx
$83655
Mar 06, 2025
Patrick Heron
Director, >10% Owner
xxxxxxxxxxxxx
$72711

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$16722105

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,735,035Insider7.62%165,387,350
2,642,263Institution5.39%116,999,406
2,261,222Institution4.61%100,126,910
1,941,068Institution3.96%85,950,491
1,911,096Institution3.90%84,623,331
1,907,812Institution3.89%84,477,915
767,707Institution1.57%33,994,066
652,011Institution1.33%28,871,047
648,193Institution1.32%28,701,986
547,566Institution1.12%24,246,222

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,642,263Institution5.39%116,999,406
1,941,068Institution3.96%85,950,491
1,907,812Institution3.89%84,477,915
767,707Institution1.57%33,994,066
652,011Institution1.33%28,871,047
648,193Institution1.32%28,701,986
430,106Institution0.88%19,045,094
404,954Institution0.83%17,931,363
337,488Institution0.69%14,943,969
320,574Institution0.65%14,195,017

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,307,390Institution2.67%62,192,542
1,068,454Institution2.18%47,311,143
609,609Institution1.24%28,999,100
471,721Institution0.96%21,019,888
348,847Institution0.71%15,446,945
233,597Institution0.48%10,343,675
188,648Institution0.38%8,406,155
181,726Institution0.37%8,644,706
114,421Institution0.23%5,443,007
89,264Institution0.18%3,952,610

FAQ

Who Owns Mirum Pharmaceuticals Inc (MIRM)?
According to the latest TipRanks data, approximately 40.60% of the company's stock is held by institutional investors, 9.43% is held by insiders, and 13.55% is held by retail investors.
    What percentage of Mirum Pharmaceuticals Inc (MIRM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 40.60% of Mirum Pharmaceuticals Inc (MIRM) stock is held by institutional investors.
      What percentage of Mirum Pharmaceuticals Inc (MIRM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 13.55% of Mirum Pharmaceuticals Inc (MIRM) stock is held by retail investors.
        Who owns the most shares of Mirum Pharmaceuticals Inc (MIRM)?
        Patrick Heron owns the most shares of Mirum Pharmaceuticals Inc (MIRM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis